Dabur India

NSE: DABUR · FMCG

₹488.65

▼ -2.27%

HOLD

Illustrative research · not investment advice Demo price · quote unavailable · Fundamentals and research: sample dataset (30 Oct 2026)

Price chart

Illustrative price history · not actual market candles

A. Company overview

Ayurvedic and natural consumer products maker.

Market cap

₹87,36,985 Cr

Industry / Sector

FMCG

Segments

Website

Visit ↗

HealthcareHome & Personal CareFoods

B. Fundamental analysis (illustrative)

Revenue growth

+6.65%

Net profit growth

+26.30%

Operating margin

21.69%

EBITDA margin

26.7%

ROE

18.26%

ROCE

19.12%

Debt / Equity

0.33

EPS

₹9.85

Operating cash flow

₹1,26,217 Cr

Working capital

₹49,071 Cr

5-year revenue & profit (₹ Cr)

C. Financial statements (illustrative)

₹ Cr	FY22	FY23	FY24	FY25	FY26
Revenue	4,26,223	4,66,319	5,29,592	5,57,853	6,13,389
EBITDA	86,498	93,793	1,21,304	1,31,546	1,63,754
Net profit	54,061	58,621	75,815	82,216	1,02,346
EPS (₹)	6.9	7.68	8.47	9.26	10.05

D. Valuation analysis

P/E

49.6

P/B

11.03

EV/EBITDA

16.63

Price/Sales

3.35

EPS

₹9.85

Dividend yield

0.4%

Peer comparison — FMCG

Company	CMP	P/E	P/B	ROE	D/E
Dabur India	488.65	49.6	11.03	18.26%	0.33
Hindustan Unilever	2,474.26	43.62	4.57	26.24%	0.01
ITC Limited	463.47	14.97	5.58	26.16%	0.81
Nestle India	1,179.12	26.02	4.03	19.83%	1.37
Britannia Industries	5,842.34	51.07	3.66	25.03%	0.56
Tata Consumer Products	1,133.44	16.42	3.42	23.02%	0.35

E. Technical analysis

RSI (14)

72.77

MACD

8.95

Support

₹464.22

Resistance

₹517.97

Volume

70,64,728

Illustrative technical charts · not actual market history

Candlestick (last 50 sessions)

Price with 50-DMA & 200-DMA, volume

Fibonacci retracement levels

23.6% · ₹495.19

38.2% · ₹487.49

50.0% · ₹481.26

61.8% · ₹475.04

F. Shareholding pattern

Promoter18.9%

FII23.69%

DII23.72%

of which Mutual Funds10.91%

Public33.69%

G. SWOT analysis

Strengths

Established position in FMCG
ROE of 18.26% in demo data

Weaknesses

Limited pricing power in some segments
Cyclical exposure

Opportunities

Domestic demand growth
Expansion in Healthcare

Threats

Regulatory changes
Competitive intensity

Illustrative template points for demonstration.

H. Research conclusion

Financial strength

Conservative balance sheet

Business quality

High capital efficiency

Valuation

Premium valuation

Growth

Sales growth of 6.65%

Risk assessment

High risk

Overall

Illustrative HOLD opinion · target ₹501.09 · stop loss ₹450.05

I. Corporate actions

Dividend history (₹/share)

Year	Dividend
FY22	1.56
FY23	1.68
FY24	1.8
FY25	1.92
FY26	2.03

Bonus, splits & announcements

Bonus history: none in demo dataset
Stock split history: none in demo dataset
Board meeting for quarterly results — demo announcement